semaglutide and alzheimer's disease ameliorates restores oxytocin in APP/PS1 mice and human brain organoid models Focus: After weight loss, Alzheimer's

Cerebrolysin has specific evidence in diabetic neuropathy models

The treatment duration with Semaglutide, as experienced in the clinical trials, is tailored to balance efficacy and safety

Gunraj RE, Yang C, Liu L, Larochelle J, Candelario-Jalil E

Regular physical activity

Head to our website for talk summaries, full recordings, and further insights from this and other CCUK webinars: #Haircare #BeautyInnovation #CosmeticScience #CCUK #WebinarHighlights Recap: The Haircare Gap CCUK Webinar (21 January 2026) With over 300 RSVPs, our latest CCUK webinar highlighted just how much interest there is in closing the gap between skincare and haircare innovation